ClinConnect ClinConnect Logo
Search / Trial NCT06647264

A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Oct 16, 2024

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Artificial Intelligence Risk Perception Laparoscopic Technique Hepatobiliary Pancreatic

ClinConnect Summary

Endoscopic surgery is the most important and commonly used minimally invasive surgery technology in the field of modern surgery, especially in hepatobiliary surgery, which has become one of the conventional diagnosis and treatment methods of surgery. Compared with traditional open surgery, it has smaller trauma, faster recovery time and lower complication rate. However, the limited visual field of surgical observation caused by the narrow surgical space and the difficulty of immediate identification of key events in the surgical scene greatly increase the difficulty and complexity of endosc...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Voluntarily sign informed consent Patients who underwent hepatectomy and cholecystectomy and were followed up in the research center hospitals from July 2024 to December 2028 Complete case, imaging and operation video data
  • Exclusion Criteria:
  • Patients who had other diseases before surgery, which may affect the results of the study Patients who developed postoperative complications but could not confirm their relevance to surgery According to the judgment of the researcher, it is not suitable to participate in this study

About Nanfang Hospital, Southern Medical University

Nanfang Hospital, affiliated with Southern Medical University, is a leading medical institution in China renowned for its comprehensive clinical services and commitment to advancing healthcare through research and education. As a clinical trial sponsor, Nanfang Hospital leverages its state-of-the-art facilities and a multidisciplinary team of expert researchers to conduct innovative studies aimed at improving patient outcomes and contributing to the global medical community. The hospital's focus on ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and scientific rigor.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Trial Officials

Kai Wang

Principal Investigator

Department of hepatobiliary surgery, Nanfang Hospital, Southern Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported